Abstract 1422: Candesartan-induced Upregulation Of Transcriptional Regulator Yin Yang 1 Blocks Leukocyte-endothelial Interaction Under Physiological Flow.

Abstract 1422: Candesartan-induced Upregulation Of Transcriptional Regulator Yin Yang 1 Blocks Leukocyte-endothelial Interaction Under Physiological Flow.
复制标题

摘要 1422:坎地沙坦诱导的转录调节因子阴阳 1 的上调可阻断生理流下白细胞与内皮细胞的相互作用。

DOI:
--
复制
发表时间:
2007
期刊:
影响因子:
37.8
通讯作者:
M. Yoshida
M. Yoshida
中科院分区:
医学1区
文献类型:
--
作者:
H. Ishii;Daisuke Mori;Mayuko Sato;M. Yoshida

文献摘要

被引文献

相似文献

[目的]炎症相关基因的转录调控在动脉粥样硬化中起重要作用。我们已经报道了Yin Yang 1(YY 1)(一种转录调节因子)在血管平滑肌细胞增殖中的主导作用(圣地亚哥FS,石井H,et al. Circ Res in press)。然而,其在血管内皮中的作用仍不清楚。最近的观察指出血管紧张素II的一种新的“基因组”效应影响炎症。在这项研究中,我们研究了YY 1在血管紧张素II型受体阻滞剂(ARB)介导的白细胞-内皮细胞粘附调节流动条件下的潜在贡献。[方法和结果]将人脐静脉内皮细胞(HUVEC)与TNFα(5 ng/ml)共孵育4 h,加入或不加入坎地沙坦(1 μ M)。坎地沙坦可显著抑制TNFα激活的HUVEC与THP-1细胞的粘附(p <0.05)。[结论]坎地沙坦通过抑制VCAM-1的表达,上调了HUVEC中YY 1的表达,抑制了白细胞与内皮细胞的粘附。我们的研究结果表明,ARB通过YY 1依赖性机制发挥新的抗炎作用。
[Objective] Transcriptional control of inflammation-relevant genes plays an important role in atherosclerosis. We have reported a dominant role of Yin Yang 1 (YY1), a transcriptional regulator, in proliferation of vascular smooth muscle cells (Santiago FS, Ishii H, et al. Circ Res in press). However, its effect in vascular endothelium remains unclear. Recent observation points a novel “genomic” effect of Angiotensin II to influence inflammation. In this study, we examined a potential contribution of YY1 in angiotensin type II receptor blocker (ARB)-mediated modulation of leukocyte-endothelial adhesion under flow condition. [Methods and Results] Human umbilical vein endothelial cells (HUVEC) were co-incubated in the presence or absence of candesartan, an ARB (1 uM) for 4 hours with TNFα (5 ng/ml). Treatment with candesartan dramatically inhibited THP-1 cell adhesion to TNFα-activated HUVEC under static (p [Conclusion] We demonstrated that candesartan treatment upregulated YY1 in HUVEC and inhibited leukocyte-endothelial adhesion by inhibition of VCAM-1 expression. Our findings suggest a novel anti-inflammatory effect of ARB via YY1-dependent mechanisms.